Literature DB >> 22687916

Mandatory and recommended vaccination in the EU, Iceland and Norway: results of the VENICE 2010 survey on the ways of implementing national vaccination programmes.

M Haverkate1, F D'Ancona, C Giambi, K Johansen, P L Lopalco, V Cozza, E Appelgren.   

Abstract

This report provides an updated overview of recommended and mandatory vaccinations in the European Union (EU), Iceland and Norway, considering the differences in vaccine programme implementation between countries. In 2010, the Vaccine European New Integrated Collaboration Effort (VENICE) network, conducted a survey among the VENICE project gatekeepers to learn more about how national vaccination programmes are implemented, whether recommended or mandatory. Information was collected from all 27 EU Member States, Iceland and Norway. In total 15 countries do not have any mandatory vaccinations; the remaining 14 have at least one mandatory vaccination included in their programme. Vaccination against polio is mandatory for both children and adults in 12 countries; diphtheria and tetanus vaccination in 11 countries and hepatitis B vaccination in 10 countries. For eight of the 15 vaccines considered, some countries have a mixed strategy of recommended and mandatory vaccinations. Mandatory vaccination may be considered as a way of improving compliance to vaccination programmes. However, compliance with many programmes in Europe is high, using only recommendations. More information about the diversity in vaccine offer at European level may help countries to adapt vaccination strategies based on the experience of other countries. However, any proposal on vaccine strategies should be developed taking into consideration the local context habits.

Entities:  

Mesh:

Year:  2012        PMID: 22687916     DOI: 10.2807/ese.17.22.20183-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  36 in total

1.  The influence of social norms on the dynamics of vaccinating behaviour for paediatric infectious diseases.

Authors:  Tamer Oraby; Vivek Thampi; Chris T Bauch
Journal:  Proc Biol Sci       Date:  2014-02-12       Impact factor: 5.349

Review 2.  Vaccination refusal. Autonomy and permitted coercion.

Authors:  Andrzej Grzybowski; Rafał K Patryn; Jarosław Sak; Anna Zagaja
Journal:  Pathog Glob Health       Date:  2017-05-09       Impact factor: 2.894

3.  Mandatory Vaccination in Europe.

Authors:  Olivia M Vaz; Mallory K Ellingson; Paul Weiss; Samuel M Jenness; Azucena Bardají; Robert A Bednarczyk; Saad B Omer
Journal:  Pediatrics       Date:  2020-01-13       Impact factor: 7.124

Review 4.  DTaP5-HB-IPV-Hib Vaccine (Vaxelis®): A Review of its Use in Primary and Booster Vaccination.

Authors:  Yahiya Y Syed
Journal:  Paediatr Drugs       Date:  2017-02       Impact factor: 3.022

5.  Are we ready to abrogate compulsory vaccinations for children?

Authors:  Domenico Martinelli; Silvio Tafuri; Francesca Fortunato; Vanessa Cozza; Cinzia A Germinario; Rosa Prato
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

Review 6.  Mandatory vaccination for infants and children: the Italian experience.

Authors:  Giovanni Rezza
Journal:  Pathog Glob Health       Date:  2019-12-23       Impact factor: 2.894

7.  Childhood Vaccination Mandates: Scope, Sanctions, Severity, Selectivity, and Salience.

Authors:  Katie Attwell; Mark C Navin
Journal:  Milbank Q       Date:  2019-09-16       Impact factor: 4.911

8.  Validity and reliability of Turkish version of the Vaccine Hesitancy Scale.

Authors:  Özgür Önal; Hande Nur Eroğlu; Fatma Yağmur Evcil; Ahmet Nesimi Kişioğlu; Ersin Uskun
Journal:  Turk Arch Pediatr       Date:  2021-05-01

9.  Measles-mumps-rubella-varicella combination vaccine (ProQuad): a guide to its use in children in the E.U.

Authors:  Lesley J Scott
Journal:  Paediatr Drugs       Date:  2015-04       Impact factor: 3.930

10.  Addressing issues of vaccination literacy and psychological empowerment in the measles-mumps-rubella (MMR) vaccination decision-making: a qualitative study.

Authors:  Marta Fadda; Miriam K Depping; Peter J Schulz
Journal:  BMC Public Health       Date:  2015-09-02       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.